Biomarkers Study in Pancreatic Cancer
We expect to collect tissue samples from 270 pancreatic cancer patients of any stages. Since
the enrollment criteria are not limited to new patients, we expect to enroll 67 patients a
year. The patient enrollment will be completed in 4 years. Clinical follow-up will be
completed in another one year. Data analysis and correlation study may be finished in the
end of 5th year of this study.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Yi-Ming Shyr, M.D.
Principal Investigator
Taipei Veterans General Hospital,Taiwan
Department of Health : Taiwan
T3212
NCT01666184
September 2012
December 2017
Name | Location |
---|